Recently, microdosing has become very popular in the psychedelic community. Researchers are looking at the idea that even very small amounts could have a big impact. However, assertions made in online debates frequently go beyond what is supported by scientific data.
Read on to learn more!
So, what is it?
Microdosing typically involves consuming a very small quantity of a hallucinogenic drug to avoid the intense effects of larger doses. The purpose is typically to sense the effects rather than to experience an altered state.
The term does not describe one standardized medical treatment. The exact microdose is not universally agreed upon. Research protocols may vary greatly.
Why is it so popular?
The interest in microdosing is growing. It stems from the idea that even small doses of psychedelics could have a positive effect on:
1.Mood
2. Concentration
3. Creativity
4. Other factors that affect daily functioning.
This has sparked much interest in microdose capsules Calgary and related products.
Reported benefits, however, should not be assumed to be medical effects. The Canadian Center for Addiction and Mental Health states that there is still a small amount of research on microdosing. Moreover, the results are inconsistent.
What does the research say?
Psilocybin and microdosing are currently being investigated. Psilocybin microdosing is being researched specifically for its mood and psychological well-being effects in Canadian clinical trials.
There are also findings from controlled research that do not always correspond to anecdotal reports. For instance, in a double-blind, placebo-controlled study published in Translational Psychiatry, researchers examined the cognitive and psychological effects of low-dose psilocybin mushrooms and concluded that the evidence is still quite complicated.
That’s why researchers are still asking for more and larger studies with more controls.
Microdosing is not treatment
We should differentiate between experimental microdosing and the medically supervised use of psychedelics. According to Health Canada, there are no registered therapeutic products containing psilocybes in Canada. Psilocybin may be available for therapeutic use via certain approved avenues, such as clinical trials and the Special Access Program.
Understanding the risks
Even low doses of a psychoactive substance can have unexpected effects, and product strength can differ. According to Health Canada, psilocybin can lead to:
1. Anxiety
2. Confusion
3. Elevated blood pressure
4. Elevated heart rate and more.
The effect of psychedelics also differs from one person to another. Microdosing skips the intense effects such as:
1.Hallucinations
2. Disorientation.
However, some people might still have adverse experiences. These effects aren’t life-threatening. But they can be particularly concerning for people with underlying mental health or heart conditions.
Summing up
Microdosing, then, is likely more of a research space than a health and wellness practice. The more evidence becomes available, the more controlled studies will help to clarify the benefits, limitations, and risks of microdosing.